77,033 Shares in CME Group Inc. $CME Purchased by Daiichi Life Insurance Co. Ltd.

Key Points

• Daiichi Life Insurance purchased 77,033 CME Group shares worth approximately $17 million, while institutional investors and hedge funds collectively own 87.75% of the company.
• Analyst sentiment is mixed: nine analysts rate CME a Buy, six a Hold and three a Sell, resulting in an overall “Hold” consensus and an average price target of $288.56.
• CME Group exceeded quarterly earnings and revenue expectations, reporting $2.99 in EPS and $1.71 billion in revenue. The company also declared a quarterly dividend of $1.30 per share, representing a 1.9% yield.

Daiichi Life Insurance Co. Ltd. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 77,033 shares of the financial services provider's stock, valued at approximately $17,011,000.

Other large investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in CME Group in the 2nd quarter worth approximately $6,749,965,000. Norges Bank purchased a new position in shares of CME Group during the 4th quarter valued at approximately $1,523,241,000. Bank of New York Mellon Corp purchased a new position in shares of CME Group during the 2nd quarter valued at approximately $867,313,000. Alphabet Inc. acquired a new position in shares of CME Group in the 2nd quarter valued at $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of CME Group in the 2nd quarter valued at $629,771,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CME has been the topic of a number of recent analyst reports. Rothschild & Co Redburn raised shares of CME Group from a "neutral" rating to a "buy" rating and increased their price target for the stock from $316.00 to $323.00 in a report on Thursday, June 11th. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a "buy" rating to a "hold" rating and cut their price objective for the company from $286.00 to $270.00 in a report on Wednesday. Piper Sandler decreased their price objective on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating for the company in a research report on Wednesday, July 15th. Weiss Ratings lowered shares of CME Group from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Finally, TD Cowen dropped their target price on CME Group from $323.00 to $273.00 and set a "buy" rating on the stock in a research report on Monday, June 22nd. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $288.56.

Insider Activity

In related news, Director William R. Shepard bought 325 shares of the company's stock in a transaction dated Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.30% of the stock is currently owned by company insiders.

CME Group Trading Up 1.5%

Shares of NASDAQ:CME opened at $274.98 on Friday. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The firm has a market capitalization of $98.88 billion, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 3.20 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The business's 50 day moving average price is $251.17 and its 200-day moving average price is $279.65.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm's revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter last year, the company earned $2.96 EPS. On average, equities research analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 44.11%.

About CME Group

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source